COMMUNIQUÉS West-GlobeNewswire

Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
30/10/2024
WILMETTE, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]
Cannabis Means Business — a Bold New Vision for CWCBExpo
30/10/2024
The Leading New York Cannabis Trade Show & Conferences Launches an Exciting New Vision and Rebrand Reflecting the New Directions for Advancing the Vast Cannabis Industry NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- [...]
Enlitic, Inc. Joins ‘Radiology Reimagined’ Demonstration at RSNA 2024
30/10/2024
Collaborative effort highlights integration of AI into radiology workflow FORT COLLINS, Colo., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enlitic announced today that it will take part in “ Radiology Reimagined: AI, innovation [...]
Castle Connolly Private Health Partners, LLC Would Like to Recognize Sandra Gilban, MD and Peggy Elango, DO for Being Named as One of the Top 9 Concierge Doctors in New York City
30/10/2024
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- On October 14th, 2024 Gotham Magazine named two of our partner physicians as The 9 Best Concierge Doctors in NYC. Gotham Magazine is a New York City-based magazine that covers [...]
Houston Zoo Partners with BlueSprig to Enhance Inclusivity for Families with Autism
30/10/2024
The partnership brings sensory-friendly attractions to the zoo’s events, including Zoo Boo and Zoo Lights HOUSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking initiative aimed at fostering inclusivity, the [...]
Elixir Medical’s LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months
30/10/2024
Elixir Medical’s LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months —Data from Elixir’s PINNACLE I trial for calcium fragmentation in calcified coronary artery lesions presented at TCT— — [...]
Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois
30/10/2024
Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois —Données des essais cliniques PINNACLE I d’Elixir dans la fragmentation des calcifications [...]
Comprehensive Healthcare launches “What we do means more” recruitment campaign highlighting rewarding careers in community behavioral health
30/10/2024
YAKIMA, Wash., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Access to quality community behavioral healthcare is life-changing for adults, families and youth facing mental health challenges. Being a part of the team that delivers [...]
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
28/10/2024
BRISBANE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with [...]
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
28/10/2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
28/10/2024
NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
28/10/2024
SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing [...]
Certara to Participate in the Stephens Annual Investment Conference
28/10/2024
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the Stephens Annual Investment [...]
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/10/2024
CARSON CITY, Nev., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
Inari Medical Reports Third Quarter 2024 Financial Results
28/10/2024
IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
28/10/2024
GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
28/10/2024
Ninety percent of survey participants reported “some” or “significant” negative impact of IBS-C on their life Survey results presented in two poster presentations WALTHAM, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/10/2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
28/10/2024
WILMETTE, Ill., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]

Pages